In order to improve the prevention of hospital-associated bloodstream infections due to methicillin-resistant Staphylococcus aureus (“MRSA”), every hospital shall establish an MRSA control program that requires:
         (1) Identification of all MRSA-colonized patients in
    
all intensive care units, and other at-risk patients identified by the hospital, through active surveillance testing.
        (2) Isolation of identified MRSA-colonized or
    
MRSA-infected patients in an appropriate manner.
        (3) Monitoring and strict enforcement of hand hygiene
    
requirements.
        (4) Maintenance of records and reporting of cases
    
under Section 10 of this Act.
  Previous section
Next section  
 210 ILCS 83 Contents